Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S ADR
(NY:
NVO
)
135.95
-4.92 (-3.49%)
Streaming Delayed Price
Updated: 1:52 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novo Nordisk A/S ADR
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
51
52
Next >
Stock Market Rally Hits Fresh Highs As Nvidia, Novo Nordisk, Bitcoin Soar: Weekly Review
March 08, 2024
The Nasdaq and S&P 500 hit new all-time highs.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Retail Traders Ditch Tesla, Apple, Google For Pharma Stocks Like Ozempic-Maker Novo Nordisk And Eli Lilly: JPMorgan
March 08, 2024
Retail traders have been observed to be selling off their shares in the 'Magnificent Seven' tech stocks, with a noticeable shift towards pharmaceutical stocks, according to a recent report by...
Via
Benzinga
Cannabis With Ozempic, Wegovy, Other Weight-Loss Drugs: Here's What You Need To Know If You're Combining Them
March 07, 2024
The study which comes amid the expansion of legal cannabis in the U.S. and the increased popularity of weight-loss treatments addressed the growing use of Glucagon-like peptide-1 (GLP-1) receptor...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
What the Options Market Tells Us About Novo Nordisk
March 04, 2024
Via
Benzinga
The Top 3 ETFs to Buy in March 2024
March 07, 2024
Simplify your investment strategy through these top ETFs to buy, offering an excellent blend of diversification and upside.
Via
InvestorPlace
Topics
ETFs
S&P 500 Reclaims All-Time Highs As Powell Hints At Rate Cuts, Nvidia Breaks $900, Bitcoin Nears Record Levels: What's Driving Market Thursday?
March 07, 2024
The S&P 500 soared past the 5,150-point mark during midday trading in New York, reclaiming its record-high territory set earlier in the week.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Insurance Coverage For Weight Loss Drugs - Cigna Unveils Efforts To Limit Health Plans/Employers Spending
March 07, 2024
Evernorth Health Services, a Cigna subsidiary, introduces a financial guarantee in its EncircleRx program offering predictability for employers and health plans. Highlights agreements with Novo Nordisk...
Via
Benzinga
Why Viking Therapeutics Stock Is Plunging Today
March 07, 2024
The sell-off could present a buying opportunity for aggressive investors willing to bet that the obesity market will be big enough for multiple winners.
Via
The Motley Fool
Why Novo Nordisk Stock Is Jumping Today (Hint: It's Not Because of Ozempic or Wegovy)
March 07, 2024
Novo Nordisk could have another successful obesity drug on the way.
Via
The Motley Fool
American Eagle Reports Upbeat Earnings, Joins Kroger, Burlington Stores And Other Big Stocks Moving Higher On Thursday
March 07, 2024
U.S. stocks were higher, with the Dow Jones index gaining more than 150 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is MindMed (MNMD) Stock Up 32% Today?
March 07, 2024
MindMed stock is heading higher on Thursday as MNMD investors celebrate it getting breakthrough designation from the FDA!
Via
InvestorPlace
NVO Stock Alert: Novo Nordisk Pops on New Weight-Loss Drug
March 07, 2024
Novo Nordisk stock is gaining on Thursday as NVO investors react to positive news from its new weight loss drug clinical trial.
Via
InvestorPlace
Novo Nordisk's Stock Hits 52-Week High After Highly Sought After Obesity Drug Trial Data
March 07, 2024
Explore Novo Nordisk's Capital Markets Day insights! Uncover early trial success of amycretin, a potential obesity drug, with 13.1% weight loss in Phase 1. Learn about its safety and upcoming Phase 2...
Via
Benzinga
Novo Nordisk Jumps On Strong Results For New Weight-Loss Drug
March 07, 2024
Amycretin showed a 13.1% weight loss after 12 weeks in a phase 1 trial.
Via
Investor's Business Daily
Ozempic Maker Novo Nordisk To Introduce Obesity Drug Wegovy In Japan, Acknowledging Country's Rising Weight Issue
March 07, 2024
Novo Nordisk, a Danish pharmaceutical company, is set to launch its weight-loss drug, Wegovy, in Japan. This move is in response to the rising obesity rates in the country.
Via
Benzinga
Trillion-Dollar Threshold: The Next 3 Stocks Ready to Rise
March 06, 2024
With a trillion-dollar valuation in sight, these three growth companies have stocks ready to rise to meet the challenge.
Via
InvestorPlace
Novo Nordisk's Semaglutide's Multi-Beneficial Effects: Weight Loss, Improved Metabolic Markers, Liver Fat Reduction in HIV-Related Liver Disease
March 06, 2024
Novo Nordisk's Semaglutide, a breakthrough in HIV and fatty liver disease research, shows a 31% average reduction in liver fat. Novo Nordisk's trial reveals significant benefits for kidney health.
Via
Benzinga
Why Dexcom — And The Obesity Market — Could Benefit From This New FDA Win
March 06, 2024
The FDA granted Dexcom's Stelo a broad clearance, meaning people without diabetes can use it.
Via
Investor's Business Daily
Exposures
Product Safety
Escalating Demand for Obesity Drugs Creates Time-Sensitive Race for Eli Lilly, Novo Nordisk
March 06, 2024
Eli Lilly's strategic collaborations with outsourcing partners for Zepbound (tirzepatide) production. Challenges persist as Eli Lilly and Novo Nordisk address production bottlenecks amid rising...
Via
Benzinga
Is Viking Therapeutics Stock a Better Buy Than Eli Lilly and Novo Nordisk After the Latest Weight-Loss Drug News?
March 06, 2024
A new player in the multibillion-dollar weight-loss drug market could be waiting in the wings.
Via
The Motley Fool
Why Novo Nordisk Stock Tumbled by Nearly 3% on Tuesday
March 05, 2024
The hotly popular European pharmaceutical company continues to investigate how its most popular molecule can be used for different afflictions.
Via
The Motley Fool
Biden's State Of The Union: Grading His Results On Abortion Access, Drug Prices And Opium Epidemic
March 05, 2024
As President Biden prepares for his State of the Union address, he will address issues such as Bidenomics, healthcare, and the US's role in the world.
Via
Benzinga
Why Are Dialysis Provider Stocks Trading Higher On Tuesday?
March 05, 2024
Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with semaglutide 1.0 mg compared to placebo. Impact on dialysis stocks
Via
Benzinga
A New Competitor to Wegovy Could Be on the Way. Should Novo Nordisk Be Worried?
March 05, 2024
Here's why I'm not worried.
Via
The Motley Fool
Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News
March 05, 2024
Novo Nordisk tested its diabetes and weight-loss drug in patients with chronic kidney disease.
Via
Investor's Business Daily
Prediction: Eli Lilly and Novo Nordisk Stock Could Just be Getting Started. Here's Why
March 05, 2024
Eli Lilly and Novo Nordisk dominate the diabetes market thanks to blockbuster medications Mounjaro, Ozempic, and Rybelsus.
Via
The Motley Fool
Novo Nordisk Says Famed Diabetes Medicine Ozempic Reduces Risk Of Kidney Disease Progression, Data Shows
March 05, 2024
Kidney outcomes trial results by Novo Nordisk. Semaglutide 1.0 mg shows a 24% reduction in kidney disease progression, cardiovascular events, and mortality risk in type 2 diabetes and CKD.
Via
Benzinga
Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making
March 05, 2024
These three companies represent the world of biotech stocks and offer a unique blend of high risk and potentially high reward.
Via
InvestorPlace
Better Weight Loss Drug Stock: Viking Therapeutics vs. Eli Lilly
March 05, 2024
One is a reigning champion, and the other is a burgeoning contender.
Via
The Motley Fool
Jim Cramer Says Nvidia, Eli Lilly, Novo Nordisk Are Not Overvalued: 'Will Be Ready To Buy If This Market Sells Off'
March 05, 2024
Cramer suggested that the upcoming labor report could potentially trigger a buying opportunity, predicting stronger figures than expected by Wall Street.
Via
Benzinga
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
51
52
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.